Literature DB >> 2475820

Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease.

J Jankovic1, R Grossman, C Goodman, F Pirozzolo, L Schneider, Z Zhu, P Scardino, A J Garber, S G Jhingran, S Martin.   

Abstract

We transplanted autologous adrenal medullary tissue into the caudate nucleus of 3 patients with advanced Parkinson's disease. The 1st patient, a 59-year-old man with parkinsonian symptoms for 15 years, had mild improvement in his motor functioning after the operation. However, his postoperative course was characterized by prolonged drowsiness and complex visual hallucinations. The patient died suddenly 8 months after the transplant, and an autopsy revealed coronary atherosclerosis. Examination of the graft site showed necrotic adrenal medullary tissue surrounded by inflammatory cells. The 2nd patient, a 50-year-old man with a 21-year history of parkinsonian symptoms, improved the most after the procedure. The 3rd patient, a 43-year-old man with 12 years of parkinsonian symptoms, had mild improvement in his motor functioning. CSF homovanillic acid increased postoperatively in the 3 patients, but then returned to preoperative levels in all except the 2nd patient. The anatomic, neurochemical, and physiologic basis for the modest clinical improvement shown in these patients is not yet understood.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475820     DOI: 10.1212/wnl.39.9.1227

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Successful survival of grafted transgenic neural plate cells in adult central nervous system environment.

Authors:  K Uchida; A H Roach; M D Kawaja; S Toya
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

2.  Unfavorable outcome of adrenal medullary transplant for Parkinson's disease.

Authors:  L S Forno; J W Langston
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 3.  Cell-based therapies for Parkinson disease—past insights and future potential.

Authors:  Roger A Barker; Janelle Drouin-Ouellet; Malin Parmar
Journal:  Nat Rev Neurol       Date:  2015-08-04       Impact factor: 42.937

4.  Cell therapies for Parkinson's disease: how far have we come?

Authors:  Thomas B Stoker; Roger A Barker
Journal:  Regen Med       Date:  2016-11-25       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.